These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10379126)

  • 1. A case of simultaneous presence of primary endometrial carcinoma and metastasis of a breast carcinoma to the ovary after 5 years of tamoxifen therapy.
    Ishioka S; Sagae S; Kobayashi K; Sugimura M; Nishioka Y; Kudo R
    J Obstet Gynaecol Res; 1999 Apr; 25(2):113-7. PubMed ID: 10379126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial metastasis from breast cancer in a patient receiving tamoxifen therapy.
    Horn LC; Einenkel J; Baier D
    Gynecol Obstet Invest; 2000; 50(2):136-8. PubMed ID: 10965200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy.
    McCluggage WG; Bryson C; Lamki H; Boyle DD
    Int J Gynecol Pathol; 2000 Jul; 19(3):276-9. PubMed ID: 10907178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
    Hoff PM; Valero V; Buzdar AU; Singletary SE; Theriault RL; Booser D; Asmar L; Frye D; McNeese MD; Hortobagyi GN
    Cancer; 2000 May; 88(9):2054-60. PubMed ID: 10813717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies regarding tamoxifen and uterine carcinoma.
    Neven P; Vergote I
    Curr Opin Obstet Gynecol; 1998 Feb; 10(1):9-14. PubMed ID: 9484623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
    Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
    Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
    Jagavkar RS; Shakespeare TP; Stevens MJ
    Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
    Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
    Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
    Barakat RR
    J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duration of adjuvant tamoxifen therapy.
    Bilimoria MM; Jordan VC
    Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
    [No Abstract]   [Full Text] [Related]  

  • 16. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial mixed Müllerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review.
    Kaleli S; Calay Z; Altinok T; Kösebay D
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):204-8. PubMed ID: 11858901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer and tamoxifen.
    Burke C
    Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.